The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease

A. S. Kuznetsova; A. I. Dolgushina; A. A. Selyanina; T. A. Sokolova; E. R. Olevskaya; V. V. Genkel

doi:10.14341/omet12832-10003

For citations:

Kuznetsova A.S., Dolgushina A.I., Selyanina A.A., Sokolova T.A., Olevskaya E.R., Genkel V.V. The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease. Obesity and metabolism. 2022;19(3):252-260. (In Russ.) https://doi.org/10.14341/omet12832

Views PDF (Rus): 362

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Obesity and metabolism

For citations:

Cookies policy